Prototype to Pilot Not yet for sale offers a chance to run early adopter pilots with urology clinics and cancer centers to validate the 3D mapping software and the novel biopsy hardware in real-world procedures, generating performance data and case studies to accelerate commercialization.

Integrated Solution Position as an end-to-end biopsy platform combining 3D mapping software, advanced needle design, adjustable specimen lengths, and specialized pathology carriers to improve diagnostic accuracy and workflow efficiency; explore bundled or subscription-based models with clinical sites and labs.

Partnership Pathways Pursue strategic partnerships with large medical device distributors, hospital networks, and AI pathology players to scale adoption; co-development or licensing discussions with firms in AI-powered pathology or imaging to enhance integration and market reach.

Competitive Differentiation Differentiate from peers with real-time 3D feedback, longer tissue sampling from apex to base, variable-length actuation, and a protective specimen carrier designed to reduce handling errors; target markets seeking precision biopsy and improved tissue viability.

Go to Market Develop a phased GTM approach focusing on early clinics and academic centers, build pilots and reference sites, secure regulatory roadmap clarity, and leverage industry events and showcases to generate interest among urology, oncology, and pathology buyers.